SIMPONI ARIA® (golimumab)
SIMPONI ARIA - pivotal clinical trial publications
Ankylosing spondylitis (AS)
GO-ALIVE
Polyarticular juvenile idiopathic arthritis (pJIA)
GO-VIVA
Psoriatic arthritis (PsA)
GO-VIBRANT
Rheumatoid arthritis (RA)
GO-FURTHER
- Weinblatt M, Bingham C, Mendelsohn A et al. Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Ann Rheum Dis. 2013;72(3):381-389.